A. Taieb and M. Picardo, The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force, Pigment Cell Research, vol.1, issue.1, pp.27-35, 2007.
DOI : 10.1001/archderm.133.12.1525

D. Mosher, T. Fitzpatrick, and . Piebaldism, Piebaldism, Archives of Dermatology, vol.124, issue.3, pp.364-369, 1988.
DOI : 10.1001/archderm.1988.01670030030017

A. Alkhateeb, P. Fain, and A. Thody, Epidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their Families, Pigment Cell Research, vol.46, issue.3, pp.208-222, 2003.
DOI : 10.1034/j.1600-0749.2003.00032.x

G. Kent and M. Al-'abadie, Psychologic effects of vitiligo: A critical incident analysis, Journal of the American Academy of Dermatology, vol.35, issue.6, pp.895-903, 1996.
DOI : 10.1016/S0190-9622(96)90112-7

D. Parsad, S. Dogra, and A. Kanwar, Quality of life in patients with vitiligo, Health and Quality of Life Outcomes, vol.1, issue.1, pp.58-64, 2003.
DOI : 10.1186/1477-7525-1-58

K. Ezzedine, Y. Gauthier, and C. Leaute-labreze, Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): A??retrospective case series of 19 patients, Journal of the American Academy of Dermatology, vol.65, issue.5, pp.965-71
DOI : 10.1016/j.jaad.2010.08.031

R. Boissy and P. Manga, On the Etiology of Contact/Occupational Vitiligo, Pigment Cell Research, vol.75, issue.5, pp.208-222, 2004.
DOI : 10.1016/S0014-5793(99)01761-5

H. Song, G. Choi, J. Shin, R. Speeckaert, D. Wolf et al., Preservation of melanoblasts of white hair follicles of segmental vitiligo lesions: A preliminary study, Journal of the European Academy of Dermatology and Venereology, vol.15, issue.2, pp.240-242
DOI : 10.1111/j.1468-3083.2010.03710.x

S. Hann, Y. Kim, and J. Yoo, Clinical and histopathologic characteristics of trichrome vitiligo, Journal of the American Academy of Dermatology, vol.42, issue.4, pp.589-96, 2000.
DOI : 10.1016/S0190-9622(00)90170-1

V. Attili and S. Attili, Lichenoid inflammation in vitiligo ??? a clinical and histopathologic review of 210 cases*, International Journal of Dermatology, vol.27, issue.7, pp.663-672, 2008.
DOI : 10.1111/j.1365-4632.2008.03672.x

K. Ezzedine, H. Lim, and T. Suzuki, Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference, Pigment Cell & Melanoma Research, vol.7, issue.Suppl, pp.1-13
DOI : 10.1111/j.1755-148X.2012.00997.x

S. Rodriguez-cuevas, A. Lopez-chavira, Z. Del-rio, and G. , Prognostic significance of cutaneous depigmentation in Mexican patients with malignant melanoma, Arch Med Res, vol.29, pp.155-163, 1998.

R. Spritz, The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma, Genome Medicine, vol.2, issue.10, pp.78-94
DOI : 10.1186/gm199

S. Hasan, K. Dinh, and F. Lombardo, Hypopigmentation in an African patient treated with imatinib mesylate: a case report, J Natl Med Assoc, vol.95, pp.722-726, 2003.

T. Passeron and J. Ortonne, Physiopathology and genetics of vitiligo, Journal of Autoimmunity, vol.25, pp.63-71, 2005.
DOI : 10.1016/j.jaut.2005.10.001

R. Spritz, Six Decades of Vitiligo Genetics: Genome-Wide Studies Provide Insights into Autoimmune Pathogenesis, Journal of Investigative Dermatology, vol.132, issue.2, pp.268-73
DOI : 10.1038/jid.2011.321

Y. Jin, S. Birlea, and P. Fain, Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo, Nature Genetics, vol.40, issue.6, pp.676-80
DOI : 10.1093/nar/gkq973

Y. Lili, W. Yi, and J. Y. , Global Activation of CD8+ Cytotoxic T Lymphocytes Correlates with an Impairment in Regulatory T Cells in Patients with Generalized Vitiligo, PLoS ONE, vol.20, issue.5, pp.37513-37534
DOI : 10.1371/journal.pone.0037513.t002

J. Klarquist, C. Denman, and C. Hernandez, Reduced skin homing by functional Treg in vitiligo, Pigment Cell & Melanoma Research, vol.112, issue.2, pp.276-86
DOI : 10.1111/j.1755-148X.2010.00688.x

Y. Kotobuki, A. Tanemura, and L. Yang, Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris, Pigment Cell & Melanoma Research, vol.8, issue.2, pp.219-249
DOI : 10.1111/j.1755-148X.2011.00945.x

H. Yu, K. Chang, and C. Yu, Alterations in IL-6, IL-8, GM-CSF. TNF-??, and IFN-?? Release by Peripheral Mononuclear Cells in Patients with Active Vitiligo, Journal of Investigative Dermatology, vol.108, issue.4, pp.527-536, 1997.
DOI : 10.1111/1523-1747.ep12289743

R. Harning, J. Cui, and J. Bystryn, Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in Vitiligo, Journal of Investigative Dermatology, vol.97, issue.6, pp.1078-80, 1991.
DOI : 10.1111/1523-1747.ep12492607

Y. Song, E. Connor, and Y. Li, The role of tyrosinase in autoimmune vitiligo, The Lancet, vol.344, issue.8929, pp.1049-52, 1994.
DOI : 10.1016/S0140-6736(94)91709-4

M. Dell-'anna and M. Picardo, A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo, Pigment Cell Research, vol.83, issue.5, pp.406-417, 2006.
DOI : 10.1111/1523-1747.ep12289743

W. Kuhtreiber, T. Hayashi, and E. Dale, Central role of defective apoptosis in autoimmunity, Journal of Molecular Endocrinology, vol.31, issue.3, pp.373-99, 2003.
DOI : 10.1677/jme.0.0310373

N. Laddha, M. Dwivedi, and M. Mansuri, Vitiligo: interplay between oxidative stress and immune system, Experimental Dermatology, vol.24, issue.4, pp.245-50
DOI : 10.1111/exd.12103

S. Toosi, S. Orlow, and P. Manga, Vitiligo-Inducing Phenols Activate the Unfolded Protein Response in Melanocytes Resulting in Upregulation of IL6 and IL8, Journal of Investigative Dermatology, vol.132, issue.11, pp.2601-2610
DOI : 10.1038/jid.2012.181

T. Passeron and J. Ortonne, Activation of the Unfolded Protein Response in Vitiligo: The Missing Link?, Journal of Investigative Dermatology, vol.132, issue.11, pp.2502-2506
DOI : 10.1038/jid.2012.328

L. Poole, I. Das, P. Van-den-wijngaard, and R. , Review of the etiopathomechanism of vitiligo: A convergence theory, Experimental Dermatology, vol.2, issue.4, pp.145-53, 1993.
DOI : 10.1111/1523-1747.ep12497951

A. Taieb, A. Alomar, and M. Bohm, Guidelines for the management of vitiligo: the European Dermatology Forum consensus, British Journal of Dermatology, vol.131, issue.1, pp.5-19
DOI : 10.1111/j.1365-2133.2012.11197.x

M. Njoo, P. Spuls, and J. Bos, Nonsurgical repigmentation therapies in vitiligo. Metaanalysis of the literature, Arch Dermatol, vol.134, pp.1532-1572, 1998.

P. Grimes, T. Soriano, and M. Dytoc, Topical tacrolimus for repigmentation of vitiligo, Journal of the American Academy of Dermatology, vol.47, issue.5, pp.789-91, 2002.
DOI : 10.1067/mjd.2002.126250

V. Lepe, B. Moncada, and J. Castanedo-cazares, A Double-blind Randomized Trial of 0.1% Tacrolimus vs 0.05% Clobetasol for the Treatment of Childhood Vitiligo, Archives of Dermatology, vol.139, issue.5, pp.581-586, 2003.
DOI : 10.1001/archderm.139.5.581

N. Ho, E. Pope, and M. Weinstein, A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0??1% vs. clobetasol propionate 0??05% in childhood vitiligo, British Journal of Dermatology, vol.27, issue.3, pp.626-658
DOI : 10.1111/j.1365-2133.2011.10351.x

E. Baltas, Z. Csoma, and F. Ignacz, Treatment of Vitiligo With the 308-nm Xenon Chloride Excimer Laser, Archives of Dermatology, vol.138, issue.12, pp.1619-1639, 2002.
DOI : 10.1001/archderm.138.12.1613

L. Duff, F. Fontas, E. Giacchero, and D. , 308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study, Br J Dermatol, vol.163, pp.188-92

S. Gupta, B. Kumar, E. Wallaeys, and B. Goh, Epidermal grafting in vitiligo: Influence of age, site of lesion, and type of disease on outcome, Journal of the American Academy of Dermatology, vol.49, issue.1, pp.99-104, 2003.
DOI : 10.1067/mjd.2003.415

S. Yones, R. Palmer, and T. Garibaldinos, Randomized Double-blind Trial of Treatment of Vitiligo, Archives of Dermatology, vol.143, issue.5, pp.578-84, 2007.
DOI : 10.1001/archderm.143.5.578

W. Westerhof, L. Nieuweboer-krobotova, and P. Mulder, Left-Right Comparison Study of the Combination of Fluticasone Propionate and UV-A vs Either Fluticasone Propionate or UV-A Alone for the Long-term Treatment of Vitiligo, Archives of Dermatology, vol.135, issue.9, pp.1061-1067, 1999.
DOI : 10.1001/archderm.135.9.1061

N. Ostovari, T. Passeron, and J. Lacour, Lack of Efficacy of Tacrolimus in the Treatment of Vitiligo in the Absence of UV-B Exposure, Archives of Dermatology, vol.142, issue.2, pp.252-255, 2006.
DOI : 10.1001/archderm.142.2.252

K. Ongenae, L. Dierckxsens, and L. Brochez, Quality of Life and Stigmatization Profile in a Cohort of Vitiligo Patients and Effect of the Use of Camouflage, Dermatology, vol.210, issue.4, pp.279-85, 2005.
DOI : 10.1159/000084751

D. Cuyper and C. , Permanent makeup: indications and complications, Clinics in Dermatology, vol.26, issue.1, pp.30-34, 2008.
DOI : 10.1016/j.clindermatol.2007.10.009

F. Solano, S. Briganti, and M. Picardo, Hypopigmenting agents: an updated review on biological, chemical and clinical aspects, Pigment Cell Research, vol.33, issue.1, pp.550-71, 2006.
DOI : 10.1021/jf0484632

F. Boukari, J. Lacour, and J. Ortonne, Laser-assisted depigmentation for resistant vitiligo: a retrospective case series with long-term follow-up, Journal of the European Academy of Dermatology and Venereology, vol.53, issue.3, p.48
DOI : 10.1111/jdv.12038

L. Komen, L. Zwertbroek, and S. Burger, Q-switched laser depigmentation in vitiligo, most effective in active disease, British Journal of Dermatology, vol.26, issue.6, pp.1246-51
DOI : 10.1111/bjd.12571

M. Njoo, R. Vodegel, and W. Westerhof, Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser, Journal of the American Academy of Dermatology, vol.42, issue.5, pp.760-769, 2000.
DOI : 10.1067/mjd.2000.103813

J. Harris, T. Harris, and W. Weninger, A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-?? for Autoreactive CD8+ T-Cell Accumulation in the Skin, Journal of Investigative Dermatology, vol.132, issue.7, pp.1869-76
DOI : 10.1038/jid.2011.463

J. Mosenson, A. Zloza, and J. Nieland, Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo, Science Translational Medicine, vol.5, issue.174, pp.174-202
DOI : 10.1126/scitranslmed.3005127

M. Rashighi, P. Agarwal, and J. Richmond, CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo, Science Translational Medicine, vol.6, issue.223, pp.223-246
DOI : 10.1126/scitranslmed.3007811

E. Nishimura, S. Jordan, and H. Oshima, Dominant role of the niche in melanocyte stem-cell fate determination, Nature, vol.416, issue.6883, pp.854-60, 2002.
DOI : 10.1038/416854a

E. Nishimura, Melanocyte stem cells: a melanocyte reservoir in hair follicles for hair and skin pigmentation, Pigment Cell & Melanoma Research, vol.44, issue.3, pp.401-411
DOI : 10.1111/j.1755-148X.2011.00855.x

L. Li, M. Fukunaga-kalabis, and H. Yu, Human dermal stem cells differentiate into functional epidermal melanocytes, Journal of Cell Science, vol.123, issue.6, pp.853-60
DOI : 10.1242/jcs.061598

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831759

E. Nicolaidou, C. Antoniou, and A. Stratigos, Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy, Journal of the American Academy of Dermatology, vol.56, issue.2, pp.274-282, 2007.
DOI : 10.1016/j.jaad.2006.09.004

D. Thaci, S. Reitamo, G. Ensenat, and M. , Proactive disease management with 0??03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study, British Journal of Dermatology, vol.44, issue.Suppl., pp.1348-56, 2008.
DOI : 10.1111/j.1365-2133.2008.08813.x

A. Wollenberg, S. Reitamo, and G. Girolomoni, Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment, Allergy, vol.60, issue.Suppl., pp.742-50, 2008.
DOI : 10.1111/j.1398-9995.2008.01683.x

D. Breneman, A. Fleischer, J. Abramovits, and W. , Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: A randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle, Journal of the American Academy of Dermatology, vol.58, issue.6, pp.990-999, 2008.
DOI : 10.1016/j.jaad.2008.02.008

A. Paller, L. Eichenfield, and R. Kirsner, Three Times Weekly Tacrolimus Ointment Reduces Relapse in Stabilized Atopic Dermatitis: A New Paradigm for Use, PEDIATRICS, vol.122, issue.6, pp.1210-1218, 2008.
DOI : 10.1542/peds.2008-1343

T. Passeron, N. Ostovari, and W. Zakaria, Topical Tacrolimus and the 308-nm Excimer Laser, Archives of Dermatology, vol.140, issue.9, pp.1065-1074, 2004.
DOI : 10.1001/archderm.140.9.1065